Clinical Resources

Explore clinical guidelines, "how to" videos, courses, and more, or find clinical tools for a particular disease.

Main Content

Resources

By disease General resources Clinical research Education

By Disease

Find clinical resources for common movement disorders:

General Clinical Resources

"How Do I?" Video Series

Watch step-by-step explanations of the most common clinical procedures and questions.

View how-to videos »

Parkinson's disease and Parkinsonism

Dystonia

Chorea and Huntington's disease

Tremor and essential tremor

Myoclonus and startle

Spasticity

MDS Clinical Clues

Watch the Clinical Clue videos for clinical clues and pro tips from world renowned specialists.

View playlist »

Please wait while we gather your results.

Clinical Outcome Assessments

MDS-owned clinical outcome assessments, translated rating scales, and a listing of other recommended tools.

View all »

Telemedicine Resources

Discover articles, courses, reviews and more to improve patient care through telemedicine.

View all »

Patient Handouts

Handouts on movement disorder topics for physicians and patients, translated into multiple languages.

View all »

Video Case Library

Browse an archive of nearly 2,000 case videos and other multimedia.
✪ MEMBERS ONLY

View all »

Asynchronous Consultations for Movement Disorders

Free consultation service that provides clinical movement disorders consultations to local physicians in Africa.

View all »

Clinical Research

Evidence-Based Medicine Reviews

MDS's Evidence-Based Medicine Reviews use a rigorous methodological approach to outline treatment options.

Parkinson's disease

Treatments for Motor Symptoms of Parkinson's disease (2018) »

Treatments for Non-Motor Symptoms of Parkinson's Disease (2019) »

Other disorders

Treatment of Restless Legs Syndrome (2017) »

Treatments for Essential Tremor (2019) »

Treatments for Huntington's Disease (2021) »

Clinical Pearls

Read key clinical insights from the latest research in Movement Disorders Clinical Practice in easily understandable graphics.

View gallery »

Education

Latest Courses for Clinicians

Browse live, in-person and on-demand courses tailored to clinicial care.

Please wait while we gather your results.

Results Updated

5 Results Listed

Page 1 of 16
Next >>

Skip to Filters

Journal CME 39.12: Immunometabolic signature and tauopathy markers in blood cells of Progressive Supranuclear Palsy

Dec 21, 2024 - Dec 21, 2025

Experienced / Intermediate

CME Credits:1.00

906Journal CME 39.12: Immunometabolic signature and tauopathy markers in blood cells of Progressive Supranuclear PalsyJournal CME 39.12<p>The Journal CME 39.12 article provides a summary to a&nbsp;broad biological characterization of peripheral immune cells in a selected PSP cohort.</p>602024-12-21https://education.movementdisorders.org/Detail/906/Journal-CME-39-12:-Immunometabolic-signature-and-tauopathy-markers-in-blood-cells-of-Progressive-Supranuclear-Palsyhttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2024-12-21T00:00:002025-12-21T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Journal%20CME%2039.12%20-%20Disclosure_18122024022801.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the biological features of peripheral immune cells in PSP patients.</p><p>2. Assess the link between peripheral immunity and central neuropathology and the relative translational reliability of PBMCs in PSP.</p><p>3. Evaluate how this study widened the landscape of potential disease-modifying treatments for PSP.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>Marco Rosina, MS, PhD1.000/Courses/Journal-CME-39.12-Immunometabolic-signature-and-tauopathy-markers-in-blood-cells-of-Progressive-Supranuclear-Palsy.htm2024-12-21T00:02:26.24000Experienced / IntermediateOnlineBasic/Translational NeuroscienceBiomarkers &amp; Diagnostic ToolsEtiology &amp; PathophysiologyParkinson Disease/Hypokinetic Movement Disorders

Genetic Movement Disorders for Clinicians

Feb 13, 2025 - Mar 13, 2025

Foundational / Beginner

902Genetic Movement Disorders for CliniciansThis 5-part online series&nbsp;course will provide participants with the fundamental knowledge to suspect, perform and interpret genetic testing.&nbsp;The educational content will further include discussion about some important topics such as differences in genetic techniques and analyses, assessment of pathogenicity and interpretation of the results, the case of &ldquo;double-trouble&rdquo; and the importance of back-phenotyping. This online course will incorporate case presentations from junior delegates to ensure a highly interactive program.<span data-teams="true"><span class="ui-provider a b c d e f g h i j k l m n o p q r s t u v w x y z ab ac ae af ag ah ai aj ak" dir="ltr"><span style="font-size:inherit;"></span></span><strong></strong></span>1200001-01-01https://education.movementdisorders.org/Detail/902/MDS-ES-Genetic-Movement-Disorders-for-Clinicianshttps://education.movementdisorders.org/Upload/ActivityImages/25-MDS-ES-Genetic-818907.jpg2025-02-13T00:00:002025-03-13T00:00:00MDS Education<p><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Preliminary_MDS-ES%20Genetic%20Movement%20Disorders%20for%20Clinicians_11122024014552.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/1733945513728_11122024013152.png" class="fr-fic fr-dii" style="width: 125px; height: 125px;"></a><strong>Course Schedule&nbsp;</strong><strong>&nbsp;</strong><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/25ESSERIES_Faculty%20Listing%20(CD)_19122024040115.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/1733945513883_11122024013153.png" class="fr-fic fr-dii" style="width: 125px; height: 125px;"></a><strong>Course Faculty&nbsp;</strong></p><p><span style="color: rgb(184, 49, 47);"><br></span></p><p><span style="color: rgb(0, 0, 0);"><em>Schedule as of December 11, 2024.</em></span></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:&nbsp;</strong>$0 USD<br><strong>Non-Members:</strong>&nbsp;$25 USD</p><p>*<em>Non-members wishing to&nbsp;</em><a href="https://www.movementdisorders.org/membership" rel="noopener noreferrer" target="_blank"><em>apply for MDS Membership</em></a><em>&nbsp;to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em></p><p><br></p><p><strong>COURSE SCHEDULE</strong><strong><em>&nbsp;</em></strong></p><p>Thursday, February 13, 2025 &nbsp;| 16:00 - 17:30 CET</p><p>Thursday, February 20, 2025| 16:00 - 17:30 CET&nbsp;</p><p>Thursday, February 27, 2025| 16:00 - 17:30 CET<br>Thursday, March 6, 2025 | 16:00 - 17:30 CET</p><p>Thursday, March 13, 2025 | 16:00 - 17:30 CET</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:&nbsp;</p><p>1. Identify the most common genetic movement disorders</p><p>2. Describe the most appropriate genetic analyses to perform in selected cases</p><p>3. Summarize and remark on the genetic reporting</p><p>4. Describe the main issue with regards to genetic analysis</p><p>5. Compare genetic findings to assess pathogenicity and relevance to the clinical phenotype</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p><span style="color: rgb(0, 0, 0);">This activity is intended for Clinician and Faculty Movement Disorder Specialist, Movement Disorder and Clinical Fellows, Neurology Residents and Genetic Counseling Health Professionals.&nbsp;</span></p>0.000/Courses/Genetic-Movement-Disorders-for-Clinicians.htm2024-12-18T11:32:55.05300Foundational / BeginnerLiveBiomarkers &amp; Diagnostic ToolsGeneticsOther Movement DisordersTherapies-Other

Cell Models of Parkinson’s Disease

Dec 09, 2024 - Dec 09, 2027

Foundational / Beginner

CME Credits:1.00

663Cell Models of Parkinson’s DiseaseThe Cell Models of Parkinson's Disease module provides an introductory course on cellular models of Parkinson&rsquo;s disease, their strengths and limitations, their use in experimental and pre-clinical applications and how to critically interpret findings in research and translational contexts.&nbsp;602024-12-09https://education.movementdisorders.org/Detail/663/Cell-Models-of-Parkinson’s-Diseasehttps://education.movementdisorders.org/Upload/ActivityImages/Cell-Models_202x108161054.png2024-12-09T00:00:002027-12-09T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty%20Disclosures%20-%20Cell%20Models%20of%20PD_21082024014214.pdf" rel="noopener noreferrer" target="_blank">HERE.</a> All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION&nbsp;</strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Tiago Outeiro, PhD - University Medical Center Goettingen, Goettingen, Germany</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Discuss cell models of Parkinson&rsquo;s disease and their pathological basis.<br>2. Define the strengths and limitations of Parkinson&rsquo;s disease cell models and contextualize their extrapolability.<br>3. Outline the use of Parkinson&rsquo;s disease cell models in experimental and pre-clinical settings and how to critically interpret findings.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p><span data-contrast="auto" lang="EN-US">This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</span><span data-ccp-props='{"201341983":0,"335559740":259}'>&nbsp;</span></p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>Tiago Outeiro, PhD1.00https://education.movementdisorders.org/Upload/BannerImages/05INTERACT-36-001-min569133.jpg0/Courses/Cell-Models-of-Parkinsons-Disease.htm2024-12-19T10:29:53.62000Foundational / BeginnerOnlineBasic/Translational NeuroscienceParkinson Disease/Hypokinetic Movement Disorders

Journal CME 39.11: Skin Tau Quantification as a Novel Biomarker in Huntington's Disease

Nov 21, 2024 - Nov 21, 2025

Experienced / Intermediate

CME Credits:1.00

901Journal CME 39.11: Skin Tau Quantification as a Novel Biomarker in Huntington's DiseaseJournal CME 39.11The Journal CME 39.11 article provides an investigation on skin tau quantification as a potential biomarker for Huntington's disease and its correlation with disease burden outcomes.602024-11-21https://education.movementdisorders.org/Detail/901/Journal-CME-39-11:-Skin-Tau-Quantification-as-a-Novel-Biomarker-in-Huntington's-Diseasehttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2024-11-21T00:00:002025-11-21T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Journal%20CME%2039.11%20%E2%80%93%20Disclosures_08112024014850.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:&nbsp;</p><p>1. Understand how skin tau quantification could serve as a potential biomarker for the pathophysiology of Huntington&rsquo;s disease&nbsp;</p><p>2. Assess how using skin tau levels in cluster analysis along with genetic and clinical measures could lead to improved subject stratification</p><p>3. Evaluate how tau levels could capture significant changes during disease progression</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>Iñigo Ruiz-Barrio, MD1.000/Courses/Journal-CME-39.11-Skin-Tau-Quantification-as-a-Novel-Biomarker-in-Huntingtons-Disease.htm2024-11-21T00:01:15.25700Experienced / IntermediateOnlineBiomarkers &amp; Diagnostic ToolsHyperkinetic Movement Disorders

Functional Movement Disorders

Nov 20, 2024 - Nov 20, 2027

Foundational / Beginner

CME Credits:1.00

806Functional Movement DisordersThis module will discuss the definition, possible aetiologic factors (neurobiology) and diagnostic criteria of functional movement disorders. The different clinical presentations, practical approach to evaluation via detailed history and exam, role of investigations and multi-disciplinary approach to management will also be discussed.602024-11-20https://education.movementdisorders.org/Detail/806/Functional-Movement-Disordershttps://education.movementdisorders.org/Upload/ActivityImages/Functional-Movement-Disorders341446.jpg2024-11-20T00:00:002027-11-20T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty Disclosure (1)_12042024015335.pdf" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION&nbsp;</strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Shilpa Chitnis, MD, PhD - UT Southwestern Medical Center, Dallas, TX, USA</p><p>Sanjay Pandey, DM - Amrita Hospital, Faridabad, Delhi NCR, India</p><p>Soaham Desai, MD, DM - Shree Krishna Hospital Pramukhswami Medical College Bhaikaka University, Anand, India</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:&nbsp;</p><p>1. Identify the different clinical presentations of functional movement disorders.</p><p>2. Recognize and examine for positive signs that rule-in a diagnosis of functional movement disorders.</p><p>3. Outline a practical approach to the clinical evaluation and management of functional movement disorders.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>Shilpa Chitnis, MD, PhD, Sanjay Pandey, MD, DM, Soaham Desai, MD, DM1.000/Courses/Functional-Movement-Disorders.htm2024-12-09T12:38:50.45300Foundational / BeginnerOnlineHyperkinetic Movement DisordersOther Movement DisordersParkinson Disease/Hypokinetic Movement Disorders

Page 1 of 16
Next >>

Get More Clinical Support

Join MDS

Members gain access to case videos, peer-to-peer collaboration opportunities, discounted education, and a variety of specialized programs.

Learn more »

Attend the International Congress

Discover the latest in the field, and connect with leaders from around the globe.

Learn more »

Clinical Resources

Resources

By Disease

Parkinson's Disease & Parkinsonism

Tremor & Essential Tremor

Rare Movement Disorders

Dystonia

Myoclonus & Startle

Stiff Person Spectrum Disorder

Chorea & Huntington's Disease

Tics & Tourette Syndrome

Gait Disorders

Ataxia

Restless Legs Syndrome (RLS)

Spasticity

General Clinical Resources

"How Do I?" Video Series

MDS Clinical Clues

Clinical Research

Evidence-Based Medicine Reviews

Clinical Pearls

Education

Latest Courses for Clinicians

Filter Clinical Courses

Search courses

Level

Format

Topic

Get More Clinical Support

Join MDS

Attend the International Congress

Your Privacy

Strictly Necessary

Performance

Targeting/Advertising

Your Privacy

Strictly Necessary

Performance

Targeting/Advertising

ASP.NET Framework

Titan CMS Authentication

Google Tag Manager

Titan Consent Manager

Facebook Connect

Google AdWords Tracking

Google Analytics